New synthetic molecules trigger immune response to HIV and prostate cancer
Friday, November 6, 2009 - 01:56
in Health & Medicine
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.
Read the whole article on Biology News Net
More from Biology News Net
Related
- New synthetic molecules trigger immune response to HIV and prostate cancerThu, 5 Nov 2009, 18:13:30 EST
- Synthetic moleculues could add spice to fight against cancerSun, 17 Aug 2008, 19:28:21 EDT
- Purdue researchers create prostate cancer 'homing device' for drug deliveryMon, 6 Jul 2009, 16:44:24 EDT
- OHSU Cancer Institute finds that drug stimulated immune system in prostate cancerMon, 2 Jun 2008, 14:14:53 EDT
- Autoimmune response can induce pancreatic tumor rejectionTue, 8 Sep 2009, 13:38:32 EDT